Thomas Beetham
Equibles does not estimate personal net worth.
About Thomas Beetham
Thomas Beetham is recorded as COO at Viridian Therapeutics, Inc.\DE (VRDN). The newest filing on record that lists Thomas Beetham as COO at Viridian Therapeutics, Inc.\DE (VRDN) is dated April 17, 2026. Viridian Therapeutics, Inc.\DE reported in an 8-K filed October 30, 2023 that Thomas Beetham was appointed Chief Operating Officer, effective October 30, 2023. The proxy statement of Viridian Therapeutics, Inc.\DE reports total compensation of $3,761,182 for Thomas Beetham in fiscal 2025, including a base salary of $545,001. Disclosed compensation is on record for 5 fiscal years. Viridian Therapeutics, Inc.\DE is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Viridian Therapeutics, Inc.\DE includes Scott Myers (CEO and Board Member), Stephen Mahoney (CEO and Board Member), Tomas Kiselak (Chairman) and 7 others.
“Also on October 30, 2023, the Company announced the appointment of Thomas Beetham as the Company's Chief Operating Officer, effective immediately.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 17, 2026
Company network
Leadership on record at Viridian Therapeutics, Inc.\DE
- Scott Myers CEO, Board Member
- Stephen Mahoney CEO, Board Member
- Tomas Kiselak Chairman
- Seth Harmon CFO
- Jonathan Violin COO
- Lee Rauch COO, Board Member
- Lara Meisner General Counsel
- Kristian Humer Chief Accounting Officer
- Arlene M. Morris Board Member
- Chris Cain Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Operating Officer | $545,001 | $3,761,182 |
| 2024 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Operating Officer | $500,000 | $809,500 |
| 2023 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Operating Officer | $86,806 | $4,761,402 |
| 2022 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Operating Officer | — | — |
| 2021 | Viridian Therapeutics, Inc.\DE (VRDN) | Chief Operating Officer | — | — |